These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14387793)

  • 1. Radioactive yttrium (Y90) as a possible adjunct in the treatment of papillomatosis of the urinary bladder.
    EINHORN J; LARSSON LG; RAGNHULT I
    Acta Radiol (Stockh); 1955 Apr; 43(4):298-304. PubMed ID: 14387793
    [No Abstract]   [Full Text] [Related]  

  • 2. Colloidal As76-2-S3; its production and possible use in the treatment of papillomatosis of the urinary bladder.
    WALINDER G
    Acta Radiol (Stockh); 1955 Dec; 44(6):521-6. PubMed ID: 13301967
    [No Abstract]   [Full Text] [Related]  

  • 3. [Depositing of radioactive yttrium (Y90) in tissue for interstitial beta-ray application].
    WINKLER C
    Klin Wochenschr; 1956 Oct; 34(37-38):1038-40. PubMed ID: 13377635
    [No Abstract]   [Full Text] [Related]  

  • 4. TREATMENT OF PAPILLOMATOSIS OF THE BLADDER WITH RADIOACTIVE ARSENIC 76-AS.
    EINHORN J; HULTBERG S; NILSON AE
    Acta Radiol Ther Phys Biol; 1964 Feb; 2():1-16. PubMed ID: 14153758
    [No Abstract]   [Full Text] [Related]  

  • 5. The retention of radioactive strontium and yttrium (Sr89, Sr90 and Y90) in pregnant and lactating rabbits and their offspring.
    KIDMAN B; TUTT ML; VAUGHAN JM
    J Pathol Bacteriol; 1951 Apr; 63(2):253-68. PubMed ID: 14851165
    [No Abstract]   [Full Text] [Related]  

  • 6. [The dosimetry of beta radiation of radioactive isotopes in air equivalent substances (with special reference to P32 and to Sr90 and Y90)].
    SOMMERMEYER K
    Strahlentherapie; 1954 Oct; 95(2):302-11. PubMed ID: 13226074
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioyttrium (Y90) for the palliative treatment of effusions due to malignancy.
    SIEGEL EP; HART HE; BROTHERS M; SPENCER H; LASZLO D
    J Am Med Assoc; 1956 Jun; 161(6):499-503. PubMed ID: 13318950
    [No Abstract]   [Full Text] [Related]  

  • 8. Animal distribution of colloids of Au198, P32, and Y90: an improved method of tissue assay for radioactivity.
    LAHR TN; OLSEN R; GLEASON GI; TABERN DL
    J Lab Clin Med; 1955 Jan; 45(1):66-80. PubMed ID: 13233629
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hematological studies on the guinea pig after the incorporation of radionuclides in high doses. II. Peripheral blood picture changes after incorporation of Y90, Y91 and Ce144].
    SPODE E
    Strahlentherapie; 1962 Apr; 117():546-59. PubMed ID: 13915879
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of chelates on the matabolism of radioyttrium (Y90). III.
    DUDLEY HC; GREENBERG J
    J Lab Clin Med; 1958 Oct; 52(4):533-40. PubMed ID: 13588165
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of multiple myeloma with radiotytrium (Y90).
    GREENBERG J; SAWITSKY A; WEISFUSE L; LEVY RN; RAI KR; DUDLEY HC
    J Lab Clin Med; 1962 Jun; 59():898-904. PubMed ID: 13901479
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new technic of transnasal hypophysis removal with Y90].
    NOTTER G; HELANDER CG; WALINDER G
    Strahlentherapie; 1959; Suppl 43():137-44. PubMed ID: 14427733
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of chelates on the metabolism of radioyttrium (Y90). II.
    DUDLEY HC; GREENBERG J
    J Lab Clin Med; 1956 Jun; 47(6):891-7. PubMed ID: 13319900
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dose measurement on Y90 pearls in elimination of the hypophysis].
    NOTTER G; WALINDER G
    Strahlentherapie; 1959 Sep; 110():95-100. PubMed ID: 14427734
    [No Abstract]   [Full Text] [Related]  

  • 15. A technique for destruction of the hypophysis using Y90-spheres. A radiologic, endocrine and histologic study.
    NOTTER G
    Acta Radiol Suppl; 1959; 184():1-128. PubMed ID: 14427735
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of papilloma of bladder with radioactive colloidal gold Au198.
    ELLIS F; OLIVER R
    Br Med J; 1955 Jan; 1(4906):136-9. PubMed ID: 13219361
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioactive colloidal yttrium silicate in the treatment of malignant effusions. I. Clinical aspects and investigations.
    WALTER J; JONES JC; FISHER M
    Br J Radiol; 1961 Jun; 34():337-46. PubMed ID: 13782949
    [No Abstract]   [Full Text] [Related]  

  • 18. [Implantation of radioactive yttrium (Y90) in the sella turcica in the treatment of breast and prostate carcinoma in the advanced stage (considerations on 21 cases)].
    GOFFRINI P; FESANI F; PERACCHIA A
    Arch Ital Chir; 1959; 85():269-302. PubMed ID: 13850467
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioactive colloidal yttrium silicate in the treatment of malignant effusions. II. Calculations of tissue dosage.
    JONES JC
    Br J Radiol; 1961 Jun; 34():346-50. PubMed ID: 13790543
    [No Abstract]   [Full Text] [Related]  

  • 20. RADIOACTIVE YTTRIUM 90: A REVIEW OF ITS PROPERTIES, BIOLOGICAL BEHAVIOR, AND CLINICAL USES.
    WALKER LA
    Acta Radiol Ther Phys Biol; 1964 Aug; 2():302-14. PubMed ID: 14203057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.